The global patient monitoring market size was estimated at USD 32.40 Billion in 2024 and worth USD 46.51 Billion by 2029, showcasing a CAGR of 7.5% from 2024 to 2032.
The growing incidence of chronic diseases and the aging population, as the increasing adoption of home healthcare and remote patient monitoring, are accelerating the growth of the global patient monitoring market.
Wearable medical monitoring devices, biosensors, and smart implants are used for various purposes, including continuous glucose monitoring, temperature monitoring, blood pressure monitoring, and pulse oximetry. The Internet of Things is built into the first generation of wearable gadgets. Wearable biosensors monitor vital signs, including blood pressure, weight, blood sugar, and electrocardiography (ECG), then send them to a central server through mobile wireless networks. Increased prevalence of patients suffering from various lifestyle disorders such as diabetes, cancer, atherosclerosis, and an uptick in online patient tracking systems. Collaborations between companies, hospitals, and universities are likely to result in the release of new devices and increased recognition and acceptance of such utilities by physicians and healthcare professionals. Various advantages of continuous patient monitoring systems, such as lower ICU usage, shorter hospital stays, and a simple warning system, would propel the patient monitoring market forward.
The increasing demand for patient monitoring devices in hospitals and non-hospital settings provides growth opportunities to the market. In addition, rising investments in developing advanced featured devices in the medical sector are promoting the growth of the patient monitoring market. Also, emerging markets in different regions offer opportunities for players to enter the patient monitoring market.
However, the risks associated with patient monitoring devices hinder the overall growth of the global patient monitoring market. In addition, the shortage of skilled persons to operate the devices is another major factor impeding the market growth.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2032 |
Base Year |
2023 |
Forecast Period |
2024 to 2032 |
Segments Covered |
By Application and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis; Porter's Five Forces Analysis, Competitive Landscape; Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
MARKET LEADERS PROFILED |
Covidien, Abbott Laboratories, Drager, Medical GmbH, GE Healthcare, Johnson & Johnson Inc., Masimo Corporation, Mindray Medical, Mortara Instrument Inc., Natus, Nihon Kohden, Nonin Medical, Omron Healthcare, Philips Healthcare, Roche Diagnostics Limited, and Welch Allyn. |
Based on the application, the multi-parameter monitoring devices segment led the patient monitoring market in 2023 and accounted for the largest market share in 2023.
The neuromonitoring devices segment is anticipated to grow at a promising CAGR during the forecast period. Under this segment, EEG machines are the segment to account for the largest share of the neuromonitoring devices market in 2023 and are expected to maintain this trend during the forecast period. Due to the growing incidence and prevalence of neurological disorders, increasing research and development in cerebral and spinal disorders, and the increasing number of EEG Labs and sleep centers.
The respiratory monitoring devices are subdivided into pulse oximeters, capnography, spirometers, and peak flow meters. The capnography segment is anticipated to show the highest growth rate during the forecast period. It is mainly due to the compulsory anesthesia provision of these instruments and the patients & respiratory condition monitoring in ICUs.
Geographically, the patient monitoring market in North America accounted for the most significant share of the global market in 2023. The significant factors backing the market's growth in this region are the aging population and increased lifestyle diseases that further serve the overall prevalence of chronic diseases followed by Europe. However, these regions' growth is expected to be slow in the forecast period due to decreasing birth rates, irregular reimbursement policies, and a reduced number of beds in hospitals.
The patient monitoring market in Europe is estimated to be a CAGR of 7.10% from 2024 to 2032.
The patient monitoring market in Asia Pacific is projected to grow at the highest CAGR over the forecast period. Asia-Pacific is the most favorable and promising region for patient monitoring devices in the coming few years. The improved purchasing power of patients and a high population base are the major drivers propelling the market in this region. Besides, the economic instability in the western countries facilitates the companies to plan their business more in the Asia-Pacific region and meet their revenue targets. On the flip side, patient privacy concerns & lack of proper reimbursement policies, and the high cost of Patient Monitoring systems inhibit the market's growth.
The Latin American patient monitoring market is growing steadily. Factors such as the growing patient count suffering from chronic diseases, the rising number of surgeries being performed, and the increasing demand for patient monitoring devices in the Latin American region promote regional market growth.
The Patient Monitoring market in the Middle East & Africa is predicted to register a CAGR of 7.69% during the forecast period.
Some of the prominent companies dominating the global patient monitoring market profiled in the report are Covidien, Abbott Laboratories, Drager, Medical GmbH, GE Healthcare, Johnson & Johnson Inc., Masimo Corporation, Mindray Medical, Mortara Instrument Inc., Natus, Nihon Kohden, Nonin Medical, Omron Healthcare, Philips Healthcare, Roche Diagnostics Limited, and Welch Allyn.
By Application
By Region
Frequently Asked Questions
The global patient monitoring market size was worth USD 30.14 billion in 2023.
The multi-parameter monitoring devices had the leading share of the market in 2023.
Geographically, the North American region had the most significant share in the global market in 2023.
Covidien, Abbott Laboratories, Drager, Medical GmbH, GE Healthcare, Johnson & Johnson Inc., Masimo Corporation, Mindray Medical, Mortara Instrument Inc., Natus, Nihon Kohden, Nonin Medical, Omron Healthcare, Philips Healthcare, Roche Diagnostics Limited, and Welch Allyn are a few of the major players in the patient monitoring market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region